Schizophrenia Drugs Market to Grow at 5.6% CAGR Through 2032

July 29, 2024 Health Trends, Health Trends - Canada

Introduction

The global schizophrenia drugs market is poised to grow from USD 7.4 billion in 2022 to USD 12.6 billion by 2032, exhibiting a CAGR of 5.6% from 2023 to 2032. Schizophrenia, a severe mental disorder, typically emerges in late adolescence or early adulthood, marked by symptoms such…

Source link

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.

Schizophrenia Drugs Market to Grow at 5.6% CAGR Through 2032

Introduction

Recent Posts

Recent Comments